Skip to content

Comparison of contrast-enhanced voiding urosonography with voiding cystourethrography in pediatric vesicoureteral reflux

Comparison of contrast-enhanced voiding urosonography with voiding cystourethrography in pediatric vesicoureteral reflux

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300078764
Enrollment
Unknown
Registered
2023-12-18
Start date
2023-12-18
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

vesicoureteral reflux

Interventions

Gold Standard:voiding cystourethrography,VCUG
Index test:contrast-enhanced voiding urosonography,ce-VUS

Sponsors

The Seventh Medical Center of Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ?Prenatal diagnosis of hydronephrosis ? Duplex kidney, ureteral cyst, ureteral dilatation, abnormal bladder structure or function were found ? First febrile UTI at the age of 0-2 years ? Recurrent urinary tract infection with suspected urinary reflux ? Medical and surgical treatment requires follow-up reassessment.

Exclusion criteria

Exclusion criteria: ? Urinary tract infection was in the active stage. ? Hydronephrosis caused by extrarenal factors such as retrocaval ureter and ectopic vessels compression ? patients who had received interventional treatment such as stoma or catheterization in other hospitals at the time of admission

Design outcomes

Primary

MeasureTime frame
Vesicoureteral reflux grading in contrast-enhanced voiding urosonography;Vesicoureteral reflux grading in voiding cystourethrography;Sensitivity, specificity, positive predictive value, negative predictive value, ROC curve;

Secondary

MeasureTime frame
Parents or guardians' views on the income and risk assessment of ce-VUS ;

Countries

China

Contacts

Public ContactHuixia Zhou

The Seventh Medical Center of Chinese PLA General Hospital

huixia99999@163.com+86 151 0106 0299

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026